Extract notice to the Minister

Vosevi

Common name / Subject : sofosbuvir/velpatasvir/voxilaprévir
Name of the manufacturer : Gilead
Form : Co.
Dosage : 400 mg - 100 mg - 100 mg

Indication : Hépatite C chronique

INESSS' Recommendation
-

Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception

Evaluation published on March 01, 2018

Download Advice to minister about Vosevi

Extrait de l'Avis au ministre sur Vosevi 243 KiO

Subscribe to our newsletter now

Subscription